RxDoctor Payments Data

Michael Newman, MD

Plastic and Reconstructive Surgery · Torrance, CANPI 1669401881

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $21,754 of the $30,917 with a category attached, or 70.4%. It is spread thinly across 42 manufacturers, the largest accounting for just 20.7%. Among plastic and reconstructive surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,917in general payments, 2019–2025

Across 393 payments — averaging $78.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$6K
  • AbbVie$5K
  • Sientra, Inc.$3K
  • RTI Surgical, Inc$2K
  • Axogen$2K
  • Bimini Technologies LLC$2K
  • plus $12K from 36 others
$92,030in research payments, 2019–2025

Across 17 payments — averaging $5413.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$92K

What the payments were for

  • Consulting fees$1,8006%
  • Speaking & faculty fees$3,40011%
  • Travel & lodging$1,2554%
  • Food & beverage$21,75470%
  • Education$90%
  • Gifts$2,7009%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,917 in reported general payments places this provider in the 90th percentile of 349 plastic and reconstructive surgery providers in California.

See all plastic and reconstructive surgery providers in California

Medicare billing

Part B allowed, 2024
$23,393
Medicare patients
33
Services billed
113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$167

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Torrance

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →